InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Gill John. Director active across 1 company, notably Altimmune, Inc.. In total, 4 filings have been published. Split: 2 buys · 1 sell. Total volume traded: €110k. History available since 12 August 2022. The latest transaction was filed on 6 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
GILL JOHN is a Director of Altimmune, Inc. (XNAS). He has made 4 filings in total, and across the 4 sampled recent filings between 2023-07-06 and 2026-04-06, the reported amounts are EUR 70721 in buys and EUR 39460 in sells, with the main transaction nature listed as Acquisition.